Status:

COMPLETED

Stress Management Therapy in Patients Receiving Chemotherapy for Cancer

Lead Sponsor:

University of South Florida

Collaborating Sponsors:

National Cancer Institute (NCI)

Conditions:

Cancer

Psychological Stress

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

RATIONALE: A stress-management program may improve quality of life and reduce anxiety and depression in patients receiving chemotherapy for cancer. PURPOSE: This randomized clinical trial is studying...

Detailed Description

OBJECTIVES: Primary * Determine if a self-administered stress management intervention is effective in improving quality of life and decreasing psychological distress (anxiety and depression) in Hisp...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • At least 18 years of age
  • Newly diagnosed with cancer
  • Scheduled to receive a minimum of 4 cycles of intravenous chemotherapy
  • Able and willing to give informed consent to participate
  • EXCLUSION CRITERIA:
  • Had intravenous chemotherapy prior to study entry
  • Are scheduled to receive radiotherapy prior to the end of the fourth cycle
  • Have severe depression or other severe psychiatric disorders

Exclusion

    Key Trial Info

    Start Date :

    December 1 2006

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    May 1 2010

    Estimated Enrollment :

    442 Patients enrolled

    Trial Details

    Trial ID

    NCT00377130

    Start Date

    December 1 2006

    End Date

    May 1 2010

    Last Update

    January 31 2014

    Active Locations (51)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 13 (51 locations)

    1

    Contra Costa Regional Medical Center

    Martinez, California, United States, 94553

    2

    CCOP - Bay Area Tumor Institute

    Oakland, California, United States, 94609-3305

    3

    Bay Area Tumor Institute

    Oakland, California, United States, 94609

    4

    Howard University Cancer Center

    Washington D.C., District of Columbia, United States, 20060